SK

Shashi Kant Jain

Active Director Director DIN 07912744
DIN 07912744 First appointment Sep 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Shashi Kant Jain

Data last updated:

Shashi Kant Jain is a Director at Alegre Pharmaceuticals Private Limited (since 2017). The company operates in Pharma. Alegre Pharmaceuticals Private Limited reported revenue of ₹16 Lakh (FY 2025).

DIN 07912744
Primary Designation Director
Industry Pharma
First Appointment 06 Sep 2017
Oldest Company Age 9 yrs
Largest company Alegre Pharmaceuticals Private Limited · ₹16 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Sep 20172017₹16 Lakh (FY 2025)Active

Board colleagues of Shashi Kant Jain

Directorship timeline

Open interactive timeline →
Alegre Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shashi Kant Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashi Kant Jain

Shashi Kant Jain currently holds 1 directorship: Alegre Pharmaceuticals Private Limited (Director, since 06 Sep 2017, revenue ₹16 Lakh (FY 2025)).

Shashi Kant Jain was first appointed on 06 Sep 2017 as Director at Alegre Pharmaceuticals Private Limited.

The current boards of Shashi Kant Jain's companies include Jolly Jain (Alegre Pharmaceuticals Private Limited), Ramakant Jain (Alegre Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available